These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 631967)

  • 1. Pharmacologic studies in Bartter's syndrome: effect of DDAVP and indomethacin on renal concentrating operation. Part II.
    Radó JP; Simatupang T; Boer P; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):22-6. PubMed ID: 631967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus.
    Fichman M; Zia P; Zipser R
    Adv Prostaglandin Thromboxane Res; 1980; 7():1193-7. PubMed ID: 7369030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bartter's syndrome with normal chloride reabsorption during indomethacin treatment.
    Hornych A; Huet de Barochez Y; Bariéty J; Branca GF; Vigeral P; Girard JF; Kazatchkine M; De Gennes JL; Truffert J; Bocquet L
    Nephron; 1987; 46(2):137-43. PubMed ID: 3600922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP; Borbély L
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence for a role for prostaglandins in the mediation of impaired urinary concentrating ability in Bartter's syndrome.
    Chan JC; Gill JR; Bartter FC
    Nephron; 1983; 35(2):116-9. PubMed ID: 6621756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
    Radó JP
    Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney.
    Lieberthal W; Vasilevsky ML; Valeri CR; Levinsky NG
    Am J Physiol; 1987 Feb; 252(2 Pt 2):F331-7. PubMed ID: 3812744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J; Vallo A; Oliveros R
    Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins, potassium, and Bartter's syndrome.
    Ferris TF
    J Lab Clin Med; 1978 Nov; 92(5):663-8. PubMed ID: 361914
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS; Chen WY; Yen TS; Lai MS
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of prostaglandin synthesis and the action of vasopressin during extracellular volume expansion in the dog.
    Kövér G; Szemerédi K; Tost H
    Acta Physiol Hung; 1983; 61(3):169-84. PubMed ID: 6650187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome results from an imbalance of vasoactive hormones.
    McGiff JC
    Ann Intern Med; 1977 Sep; 87(3):369-72. PubMed ID: 900681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renal prostaglandins during antidiuresis and water diuresis in man.
    Walker RM; Brown RS; Stoff JS
    Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.